$1.03
-0.14-11.97%
At close: -
$1.03
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Akoya Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:AKYA | Benzinga
Akoya Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.180
Quarterly Revenue Estimate
$20.19M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$81.67M
Analyze the earnings history of Akoya Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKYA | Akoya Biosciences | -$0.39 | -$0.18 | — | — | $18.35M | $20.19M | — | — | 05/12/2025 | Get Alert |
| AKYA | Akoya Biosciences | -$0.22 | -$0.16 | -$0.17 | -6.25% | $26.49M | $21.23M | $21.34M | 0.54% | 03/17/2025 | Get Alert |
| AKYA | Akoya Biosciences | -$0.26 | -$0.20 | -$0.21 | -5.00% | $25.21M | $25.42M | $18.81M | -25.99% | 11/14/2024 | Get Alert |
| AKYA | Akoya Biosciences | -$0.51 | -$0.27 | -$0.27 | 0.00% | $23.52M | $23.67M | $23.16M | -2.14% | 08/05/2024 | Get Alert |
| AKYA | Akoya Biosciences | -$0.49 | -$0.29 | -$0.39 | -34.48% | $21.41M | $24.28M | $18.35M | -24.42% | 05/13/2024 | Get Alert |
| AKYA | Akoya Biosciences | -$0.50 | -$0.27 | -$0.22 | 18.52% | $21.22M | $25.89M | $26.49M | 2.31% | 03/04/2024 | Get Alert |
| AKYA | Akoya Biosciences | -$0.47 | -$0.37 | -$0.26 | 29.73% | $18.85M | $24.54M | $25.21M | 2.75% | 11/08/2023 | Get Alert |
| AKYA | Akoya Biosciences | -$0.47 | -$0.44 | -$0.51 | -15.91% | $17.89M | $22.17M | $23.52M | 6.09% | 08/07/2023 | Get Alert |
| AKYA | Akoya Biosciences | -$0.44 | -$0.48 | -$0.49 | -2.08% | $16.89M | $20.32M | $21.41M | 5.36% | 05/08/2023 | Get Alert |
| AKYA | Akoya Biosciences | -$0.47 | -$0.43 | -$0.50 | -16.28% | $16.16M | $20.58M | $21.22M | 3.10% | 03/06/2023 | Get Alert |
| AKYA | Akoya Biosciences | -$0.31 | -$0.43 | -$0.47 | -9.30% | $13.48M | $17.71M | $18.85M | 6.45% | 11/07/2022 | Get Alert |
| AKYA | Akoya Biosciences | -$0.20 | -$0.37 | -$0.47 | -27.03% | $13.07M | $16.90M | $17.89M | 5.88% | 08/08/2022 | Get Alert |
| AKYA | Akoya Biosciences | -$3.54 | -$0.39 | -$0.44 | -12.82% | $12.21M | $14.93M | $16.89M | 13.15% | 05/05/2022 | Get Alert |
| AKYA | Akoya Biosciences | -$4.24 | -$0.31 | -$0.47 | -51.61% | $12.91M | $16.05M | $16.16M | 0.67% | 03/14/2022 | Get Alert |
| AKYA | Akoya Biosciences | -$2.44 | -$0.26 | -$0.31 | -19.23% | $10.00M | $12.98M | $13.48M | 3.82% | 11/08/2021 | Get Alert |
| AKYA | Akoya Biosciences | -$2.65 | -$0.22 | -$0.20 | 9.09% | $8.56M | $12.57M | $13.07M | 3.99% | 08/10/2021 | Get Alert |
| AKYA | Akoya Biosciences | — | — | -$3.54 | — | $11.00M | — | $12.21M | — | 05/18/2021 | Get Alert |
Akoya Biosciences (AKYA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-17 | $-0.17 | $-0.16 | -6.25 % |
| Q3 | 2024-11-14 | $-0.21 | $-0.20 | -5.00 % |
| Q2 | 2024-08-05 | $-0.27 | $-0.27 | 0.00 % |
| Q1 | 2024-05-13 | $-0.39 | $-0.29 | -34.5 % |
Akoya Biosciences (AKYA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-17 | $21.34M | $21.23M | 0.54 % |
| Q3 | 2024-11-14 | $18.81M | $25.42M | -26.0 % |
| Q2 | 2024-08-05 | $23.16M | $23.67M | -2.14 % |
| Q1 | 2024-05-13 | $18.35M | $24.28M | -24.4 % |
FAQ
When is Akoya Biosciences (NASDAQ:AKYA) reporting earnings?
Akoya Biosciences (AKYA) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 17, 2025 for Q4.
What were the latest earnings per share (EPS) for Akoya Biosciences (NASDAQ:AKYA)?
The Actual EPS was $-0.17, which missed the estimate of $-0.16.
What were Akoya Biosciences’s (NASDAQ:AKYA) revenues?
The Actual Revenue was $21.3M, which beat the estimate of $21.2M.
Browse earnings estimates, EPS, and revenue on all stocks.